188 related articles for article (PubMed ID: 21216590)
41. [The techniques of peritonectomy and hyperthermic intraperitoneal chemotherapy].
Lang SA; Glockzin G; Dahlke MH; Popp FC; Agha A; Schlitt HJ; Piso P
Zentralbl Chir; 2009 Sep; 134(5):443-9. PubMed ID: 19492282
[TBL] [Abstract][Full Text] [Related]
42. Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve.
Mohamed F; Moran BJ
Cancer J; 2009; 15(3):196-9. PubMed ID: 19556904
[TBL] [Abstract][Full Text] [Related]
43. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer.
Ceelen WP; Hesse U; de Hemptinne B; Pattyn P
Br J Surg; 2000 Aug; 87(8):1006-15. PubMed ID: 10931042
[TBL] [Abstract][Full Text] [Related]
44. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.
Glockzin G; Ghali N; Lang SA; Schlitt HJ; Piso P
J Surg Oncol; 2009 Sep; 100(4):306-10. PubMed ID: 19697436
[TBL] [Abstract][Full Text] [Related]
45. Learning curve of combined modality treatment in peritoneal surface disease.
Smeenk RM; Verwaal VJ; Zoetmulder FA
Br J Surg; 2007 Nov; 94(11):1408-14. PubMed ID: 17631678
[TBL] [Abstract][Full Text] [Related]
46. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Baratti D; Kusamura S; Martinetti A; Seregni E; Laterza B; Oliva DG; Deraco M
Ann Surg Oncol; 2007 Aug; 14(8):2300-8. PubMed ID: 17510772
[TBL] [Abstract][Full Text] [Related]
47. [Importance of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer].
Ferron G; Martinez A; Mery E; Querleu D; Thomas F; Chatelut E; Gladieff L
Bull Cancer; 2009 Dec; 96(12):1243-52. PubMed ID: 19948452
[TBL] [Abstract][Full Text] [Related]
48. Intraperitoneal hyperthermia in the management of pseudomyxoma peritonei.
Hsu KH; Chou CY; Chang YC
Hepatogastroenterology; 2007; 54(73):47-52. PubMed ID: 17419229
[TBL] [Abstract][Full Text] [Related]
49. Cytoreductive surgery and perioperative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
Sugarbaker PH
Tumori; 2001; 87(4):S3-5. PubMed ID: 11693816
[No Abstract] [Full Text] [Related]
50. Therapy of pseudomyxoma peritonei of appendiceal origin--surgical resection and intraperitoneal chemotherapy.
Hosch WP; Rudi J; Stremmel W
Z Gastroenterol; 1999 Jul; 37(7):615-22. PubMed ID: 10458011
[TBL] [Abstract][Full Text] [Related]
51. Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy.
van Ruth S; Verwaal VJ; Hart AA; van Slooten GW; Zoetmulder FA
Anticancer Res; 2003; 23(2B):1501-8. PubMed ID: 12820416
[TBL] [Abstract][Full Text] [Related]
52. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome.
Brouquet A; Goéré D; Lefèvre JH; Bonnet S; Dumont F; Raynard B; Elias D
Ann Surg Oncol; 2009 Oct; 16(10):2744-51. PubMed ID: 19626375
[TBL] [Abstract][Full Text] [Related]
53. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis. Preliminary results and cost from two centers in Greece.
Spiliotis J; Tentes AA; Vaxevanidou A; Korakianitis OS; Rogdakis A; Mirelis CG; Datsis AC; Kekelos S
J BUON; 2008; 13(2):205-10. PubMed ID: 18555466
[TBL] [Abstract][Full Text] [Related]
54. Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies.
Piso P; Glockzin G; von Breitenbuch P; Popp FC; Dahlke MH; Schlitt HJ; Nissan A
J Surg Oncol; 2009 Sep; 100(4):317-20. PubMed ID: 19697438
[TBL] [Abstract][Full Text] [Related]
55. Cytoreduction including total gastrectomy for pseudomyxoma peritonei.
Sugarbaker PH
Br J Surg; 2002 Feb; 89(2):208-12. PubMed ID: 11856136
[TBL] [Abstract][Full Text] [Related]
56. Cytoreductive surgery associated to hyperthermic intraperitoneal chemoperfusion for desmoplastic round small cell tumor with peritoneal carcinomatosis in young patients.
Msika S; Gruden E; Sarnacki S; Orbach D; Philippe-Chomette P; Castel B; Sabaté JM; Flamant Y; Kianmanesh R
J Pediatr Surg; 2010 Aug; 45(8):1617-21. PubMed ID: 20713209
[TBL] [Abstract][Full Text] [Related]
57. Safety of gastric resections during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis.
Piso P; Slowik P; Popp F; Dahlke MH; Glockzin G; Schlitt HJ
Ann Surg Oncol; 2009 Aug; 16(8):2188-94. PubMed ID: 19408049
[TBL] [Abstract][Full Text] [Related]
58. Colorectal cancer and peritoneal carcinomatosis.
Cintron JR; Pearl RK
Semin Surg Oncol; 1996; 12(4):267-78. PubMed ID: 8829286
[TBL] [Abstract][Full Text] [Related]
59. Cytoreduction and intraperitoneal chemotherapy for the management of non-gynecological peritoneal surface malignancy.
Yan TD; Esquivel J; Carmignani P; Sugarbaker PH
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):109-17. PubMed ID: 16767916
[TBL] [Abstract][Full Text] [Related]
60. [New treatment of peritoneal carcinomatosis from colorectal cancer. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Iversen LH; Rasmussen PC; Laurberg S
Ugeskr Laeger; 2007 Sep; 169(38):3179-81. PubMed ID: 17910824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
